FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer CancerNetwork
Gynaecological Devices Market Set to Reach USD 21.11 Billion By 2033, Due to Advances in Surgical and Diagnostic Technologies – SNS Insider Business Upturn
Proteomics $2.2M R&D rebate to fuel diagnostics test rollout The Sydney Morning Herald
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma BioSpace
Scar endometriosis is a rare form of extra-pelvic endometriosis that occurs at the site of surgical scars, most frequently after obstetric or gynaecologic procedures. This condition is often confused with …
Objectives: This study aimed to systematically compare the diagnostic accuracy of magnetic resonance imaging (MRI) and transvaginal ultrasound (TVUS) for deep infiltrating endometriosis (DIE) and to evaluate their impact on …
MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA Business Wire
Endometriosis is a significant and prevalent health issue. Delayed diagnosis is common and the associated delay to treatment is associated with high socioeconomic and personal costs including chronic pain, infertility …
Endometriosis-associated ovarian cancer (EAOC) mainly includes endometrioid ovarian cancer (ENOC) and clear cell ovarian cancer (CCOC). The Cancer Genome Atlas (TCGA) revealed four molecular subtypes of endometrial cancer (EC) in …
EndoDiagnosis, Inc Exhibits TIER-1 ENDOSURE Diagnostic Test for Endometriosis at AAGL 2025 in Vancouver, BC, Canada Florida Today